- View Association of Telomere Length With Risk of Disease and Mortality Currently reading
In Brief | Critical Care | Genetic Medicine
Association of Telomere Length With Risk of Disease and Mortality
Time to read: 01:12
Published on MedED: 21 January 2022
Originally Published: 28 January 2022
Source: JAMA Internal Medicine
Type of article: In Brief
MedED Catalogue Reference: MCC006
MedED Cross Reference: Gerontology, Genetics
Keywords: leukocyte telomere length (LTL), mortality, telomeres, DNA
Originally published in JAMA Internal Medicine, 28 January 2023. This summary does not represent the original research, nor is it intended to replace the original research. Access the full Disclaimer Information
This original research presents the findings of a multicenter, community-based cohort study that aimed to determine the association between leukocyte telomere length (LTL) and mortality and morbidity. Telomeres play a crucial role in protecting DNA, and their shortening with each mitotic cycle is a cellular ageing marker.
The study included 472,432 English participants from the United Kingdom Biobank and followed them for an average of 12 years. The analysis adjusted for age, sex, body mass index, and ethnicity.
The results showed that reduced LTL was associated with increased overall mortality. Specifically, shorter LTL was linked to higher cardiovascular, respiratory, digestive, musculoskeletal, and COVID-19-related mortality risks. However, there was no significant association between LTL and cancer-related mortality.
In addition to mortality, the study examined morbidity and found that participants with shorter LTL had a higher prevalence of various disorders. Respiratory, digestive/liver-related, circulatory, and musculoskeletal conditions and infections were most strongly associated with shorter LTL. On the other hand, benign neoplasms and endocrinologic/metabolic disorders were less prevalent in participants with shorter LTL. Some specific cancers, such as oesophagal cancer and lymphoid and myeloid leukaemia, were more common in individuals with shorter LTL, while brain cancer and melanoma were less prevalent.
The study also noted that smoking and alcohol consumption were associated with shorter LTL. However, adjusting for these factors, cognitive function and major comorbid conditions did not significantly change the results.
In conclusion, this cohort study demonstrated that shorter leukocyte telomere length is associated with a small increase in overall mortality risk and a higher risk of mortality related to specific organs and diseases. These findings highlight the potential of LTL as a biomarker for predicting health outcomes and identifying individuals at higher risk of certain conditions.
Back to top
Disclaimer
This article is compiled from a variety of resources researched and compiled by the contributor. It is in no way presented as an original work. Every effort has been made to attribute quotes and content correctly. Where possible, all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us
Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.
